1. Recognize cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) for T-cell engaging therapies

2. Manage CRS and ICANS based on institution’s guideline

Session date: 
01/08/2026 - 8:00am to 9:00am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Young Bae, PharmD, BCOP